Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer

Anticancer Res. 2006 Mar-Apr;26(2A):829-32.

Abstract

Background: The presence of human papillomavirus (HPV), the HPV type and viral load in early stage cervical carcinoma were investigated in order to elucidate whether any of these factors were important for clinical outcome.

Patients and methods: Twelve patients who were disease-free 5 years after diagnosis were matched and compared with 12 patients who died within 2 years. The presence of HPV, HPV type and viral load in their tumours was examined by PCR.

Results: The distribution and load of HPV was similar in the 2 patient groups. HPV-16 was, however, significantly more common in tumours of the surviving patients than in those of patients who died (88.9% and 18.2%, respectively, p = 0.0152).

Conclusion: HPV-16 was significantly more common in early stage carcinomas of patients surviving more than 5 years in comparison to early stage carcinomas of patients with a poor prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / growth & development*
  • Human papillomavirus 18 / genetics
  • Human papillomavirus 18 / growth & development*
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / virology*
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / virology*
  • Viral Load